Search Results
Managing Myelofibrosis in 2021 - Dr. Srdan Verstovsek
Dr. Srdan Verstovsek on JAK2 Inhibitors as a Treatment for Myelofibrosis
Srdan Verstovsek, MD, on the Phase III VERIFY Trial
For Myelofibrosis Patients: Latest on Treatments from Top Doctor | Dr. Srdan Verstovsek, MD Anderson
Management of Myelofibrosis in 2023
Management of Myelofibrosis: JAK Inhibitors and Novel Therapeutics in the Peri-Transplant Setting
Future treatment strategies for MPNs
New MPN Treatments and Drugs - Srdan Verstovsek, MD, PhD
Dr. Verstovsek on Limitations of the Current Treatment Landscape of Myelofibrosis
What You Should Know About Progression in MPNs
Update on the management of patients with MPNs in transformation
Monitoring MPNs: When is it Time to Switch Therapies?
